Trial Updates
Raul Cordoba
Raul Cordoba/X

Raul Cordoba: COVID-19 and Bispecific Antibodies in Blood Cancer

Raul Cordoba, Head of the Lymphoma Unit at the Fundacion Jimenez Diaz University Hospital, shared a post on X:

”Hematology impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders.”

Title: Impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders

Authors: Ángel Serna, Víctor Navarro, Moraima Jiménez, Josu Iraola-Truchuelo, Marc Bosch, Cristina García, Anna Falcó, Adaia Albasanz, Isabel Ruiz-Camps, Cristina Andrés, Andrés Antón, Juliana Esperalba, Ainara Ferrero, Tomás García, Cecilia Carpio, Marta Crespo, Gloria Iacoboni, Ana Marín-Niebla, Francesc Bosch, Pau Abrisqueta

You can read the Full Article on Blood Advances.

Raul Cordoba

More posts featuring Raul Cordoba.

Adaia Albasanz Ainara Ferrero Ana Marin-Niebla Andrés Antón Ángel Serna Anna Falcó blood advances cancer cancer treatment Cecilia Carpio Cristina Andrés Cristina García Francesc Bosch Fundacion Jimenez Diaz University Hospital Gloria Iacoboni Isabel Ruiz-Camps Josu Iraola-Truchuelo Juliana Esperalba Marc Bosch Marta Crespo Moraima Jiménez OncoDaily Oncology Pau Abrisqueta Raul Cordoba Tomás García Victor Navarro